125 related articles for article (PubMed ID: 38568191)
1. KLRG1, Another Opportunity for a Breakthrough in MTCL.
Varma G; Diefenbach CS
Clin Cancer Res; 2024 Jun; 30(11):2300-2302. PubMed ID: 38568191
[TBL] [Abstract][Full Text] [Related]
2. KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.
Assatova B; Willim R; Trevisani C; Haskett G; Kariya KM; Chopra K; Park SR; Tolstorukov MY; McCabe SM; Duffy J; Louissaint A; Huuhtanen J; Bhattacharya D; Mustjoki S; Koh MJ; Powers F; Morgan EA; Yang L; Pinckney B; Cotton MJ; Crabbe A; Ziemba JB; Brain I; Heavican-Foral TB; Iqbal J; Nemec R; Rider AB; Ford JG; Koh MJ; Scanlan N; Feith DJ; Loughran TP; Kim WS; Choi J; Roels J; Boehme L; Putteman T; Taghon T; Barnes JA; Johnson PC; Jacobsen ED; Greenberg SA; Weinstock DM; Jain S
Clin Cancer Res; 2024 Jun; 30(11):2514-2530. PubMed ID: 38252421
[TBL] [Abstract][Full Text] [Related]
3. Development of Antihuman Killer Cell Lectin-Like Receptor Subfamily G Member 1 Monoclonal Antibodies for Flow Cytometry.
Asano T; Nanamiya R; Tanaka T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Apr; 40(2):76-80. PubMed ID: 33900816
[TBL] [Abstract][Full Text] [Related]
4. Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1+ effector memory phenotype.
Göthert JR; Eisele L; Klein-Hitpass L; Weber S; Zesewitz ML; Sellmann L; Röth A; Pircher H; Dührsen U; Dürig J
Cancer Immunol Immunother; 2013 Nov; 62(11):1697-1709. PubMed ID: 24022692
[TBL] [Abstract][Full Text] [Related]
5. TGF-β downregulates KLRG1 expression in mouse and human CD8(+) T cells.
Schwartzkopff S; Woyciechowski S; Aichele U; Flecken T; Zhang N; Thimme R; Pircher H
Eur J Immunol; 2015 Aug; 45(8):2212-7. PubMed ID: 26014037
[TBL] [Abstract][Full Text] [Related]
6. Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing self recognition.
Li Y; Hofmann M; Wang Q; Teng L; Chlewicki LK; Pircher H; Mariuzza RA
Immunity; 2009 Jul; 31(1):35-46. PubMed ID: 19604491
[TBL] [Abstract][Full Text] [Related]
7. Expression of KLRG1 and CD127 defines distinct CD8
Wu H; Tang X; Kim HJ; Jalali S; Pritchett JC; Villasboas JC; Novak AJ; Yang ZZ; Ansell SM
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34226281
[TBL] [Abstract][Full Text] [Related]
8. KLMab-1: An Anti-human KLRG1 Monoclonal Antibody for Immunocytochemistry.
Saito M; Suzuki H; Asano T; Tanaka T; Yoshikawa T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Oct; 41(5):279-284. PubMed ID: 36306514
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic KLRG1 expressing lymphocytes invade portal tracts in primary biliary cholangitis.
Li Y; Li B; You Z; Zhang J; Wei Y; Li Y; Chen Y; Huang B; Wang Q; Miao Q; Peng Y; Fang J; Gershwin ME; Tang R; Greenberg SA; Ma X
J Autoimmun; 2019 Sep; 103():102293. PubMed ID: 31255417
[TBL] [Abstract][Full Text] [Related]
10. Transferrin' activation: bonding with transferrin receptors tunes KLRG1 function.
Steinle A
Eur J Immunol; 2014 Jun; 44(6):1600-3. PubMed ID: 24752778
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells.
Robbins SH; Nguyen KB; Takahashi N; Mikayama T; Biron CA; Brossay L
J Immunol; 2002 Mar; 168(6):2585-9. PubMed ID: 11884419
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin expression on human carcinoma cell affects trastuzumab-mediated antibody-dependent cellular cytotoxicity through killer cell lectin-like receptor G1 on natural killer cells.
Yamauchi C; Fujii S; Kimura T; Kuwata T; Wada N; Mukai H; Matsumoto N; Fukayama M; Ochiai A
Int J Cancer; 2011 May; 128(9):2125-37. PubMed ID: 21387286
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas.
Haedicke W; Ho FC; Chott A; Moretta L; Rüdiger T; Ott G; Müller-Hermelink HK
Blood; 2000 Jun; 95(11):3628-30. PubMed ID: 10828054
[TBL] [Abstract][Full Text] [Related]
14. Targeted inhibition of CD47-SIRPα requires Fc-FcγR interactions to maximize activity in T-cell lymphomas.
Jain S; Van Scoyk A; Morgan EA; Matthews A; Stevenson K; Newton G; Powers F; Autio A; Louissaint A; Pontini G; Aster JC; Luscinskas FW; Weinstock DM
Blood; 2019 Oct; 134(17):1430-1440. PubMed ID: 31383641
[TBL] [Abstract][Full Text] [Related]
15. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1).
Voehringer D; Koschella M; Pircher H
Blood; 2002 Nov; 100(10):3698-702. PubMed ID: 12393723
[TBL] [Abstract][Full Text] [Related]
16. Good news, bad news for missing-self recognition by NK cells: autoimmune control but viral evasion.
Vivier E; Romagné F
Immunity; 2007 May; 26(5):549-51. PubMed ID: 17521583
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of killer cell lectin-like receptor G1 expression on T cells.
Robbins SH; Terrizzi SC; Sydora BC; Mikayama T; Brossay L
J Immunol; 2003 Jun; 170(12):5876-85. PubMed ID: 12794113
[TBL] [Abstract][Full Text] [Related]
18. Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy.
Yang X; Zheng Y; Han Z; Zhang X
BMC Cancer; 2021 Jun; 21(1):752. PubMed ID: 34187403
[TBL] [Abstract][Full Text] [Related]
19. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G
J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683
[TBL] [Abstract][Full Text] [Related]
20. Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers.
Tata A; Dodard G; Fugère C; Leget C; Ors M; Rossi B; Vivier E; Brossay L
Oncoimmunology; 2021 Jun; 10(1):1933808. PubMed ID: 34188973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
